Yeny Acosta-Ampudia
Overview
Explore the profile of Yeny Acosta-Ampudia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monsalve D, Acosta-Ampudia Y, Acosta N, Celis-Andrade M, Sahin A, Yilmaz A, et al.
J Transl Autoimmun
. 2025 Mar;
10:100280.
PMID: 40071133
NETosis, the process through which neutrophils release neutrophil extracellular traps (NETs), has emerged as a crucial mechanism in host defense and the pathogenesis of autoimmune responses. During the SARS-CoV-2 pandemic,...
2.
Celis-Andrade M, Rojas M, Rodriguez Y, Calderon J, Rodriguez-Jimenez M, Monsalve D, et al.
Clin Rheumatol
. 2024 Sep;
43(11):3313-3322.
PMID: 39243279
Objective: To evaluate the performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in Colombian patients with systemic lupus erythematosus (SLE). Methods: The Colombian cohort included 435 SLE patients...
3.
Rojas M, Acosta-Ampudia Y, Heuer L, Zang W, Monsalve D, Ramirez-Santana C, et al.
J Autoimmun
. 2024 Aug;
148:103303.
PMID: 39141985
Autoimmune diseases (ADs) showcase the intricate balance between the immune system's protective functions and its potential for self-inflicted damage. These disorders arise from the immune system's erroneous targeting of the...
4.
Celis-Andrade M, Morales-Gonzalez V, Rojas M, Monsalve D, Acosta-Ampudia Y, Rodriguez-Jimenez M, et al.
Diabetes Metab Syndr
. 2024 Jul;
18(7):103087.
PMID: 39074403
Background: Patients afflicted by type 1 diabetes (T1D) exhibit polyautoimmunity (PolyA). However, the frequency and distribution of PolyA in T1D is still unknown. Objective: We conducted a systematic review and...
5.
Camacho-Dominguez L, Rojas M, Herran M, Rodriguez Y, Beltran S, Galindo P, et al.
BMJ Open
. 2024 Feb;
14(2):e072784.
PMID: 38355186
Background: A paucity of predictive models assessing risk factors for COVID-19 mortality that extend beyond age and gender in Latino population is evident in the current academic literature. Objectives: To...
6.
Martel F, Cuervo-Rojas J, Angel J, Ariza B, Gonzalez J, Ramirez-Santana C, et al.
Front Immunol
. 2023 Sep;
14:1274753.
PMID: 37662943
[This corrects the article DOI: 10.3389/fimmu.2023.1241038.].
7.
Morales-Gonzalez V, Galeano-Sanchez D, Covaleda-Vargas J, Rodriguez Y, Monsalve D, Pardo-Rodriguez D, et al.
Front Mol Biosci
. 2023 Aug;
10:1215039.
PMID: 37614441
Systemic sclerosis (SSc) is a chronic autoimmune disease, marked by an unpredictable course, high morbidity, and increased mortality risk that occurs especially in the diffuse and rapidly progressive forms of...
8.
Martel F, Cuervo-Rojas J, Angel J, Ariza B, Gonzalez J, Ramirez-Santana C, et al.
Front Immunol
. 2023 Aug;
14:1241038.
PMID: 37575243
The SARS CoV-2 antibody and CD4 T cell responses induced by natural infection and/or vaccination decline over time and cross-recognize other viral variants at different levels. However, there are few...
9.
Rojas M, Rodriguez Y, Hernandez J, Diaz-Coronado J, Daza Vergara J, Velez V, et al.
BMC Infect Dis
. 2022 Jun;
22(1):575.
PMID: 35761219
Background: Convalescent plasma (CP) has been widely used to treat COVID-19 and is under study. However, the variability in the current clinical trials has averted its wide use in the...
10.
Acosta-Ampudia Y, Anaya J
J Infect Dis
. 2022 Mar;
226(4):753-754.
PMID: 35313345
No abstract available.